The present study supported evidence that PXR expression in breast cancer was associated with crucial clinicopathological parameters for patients’ management and prognosis, supporting evidence for a potential important role of PXR in the biological mechanisms governing breast malignant disease progression. This evidence concerns the gene NR1I2 and breast cancer.